Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)

SHA:688739 Revenue

Liaoning Chengda Biotechnology had revenue of 403.92M CNY in the quarter ending June 30, 2026, with 15.94% growth. This brings the company's total for the last twelve months to 1.36B, down -9.42% year-over-year. In the year 2025, Liaoning Chengda Biotechnology had annual revenue of 1.39B, down -17.06%. That makes Liaoning Chengda Biotechnology the 17,364th largest company in the world by revenue and 3,148th in China.

• Revenue (ttm): 1.36B
• Revenue Growth: -9.42%
• P/S Ratio: 6.04
• Revenue / Employee: 858.53K
• Employees: 1,585
• Market Cap: 8.22B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.15B 82.6%
• Overseas 241.92M 17.4%

Fiscal year ended Dec 31, 2025 See the full SHA:688739 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.39B	-285.95M	-17.06%
Dec 31, 2024	1.68B	-73.86M	-4.22%
Dec 31, 2023	1.75B	-64.90M	-3.58%
Dec 31, 2022	1.81B	-273.04M	-13.08%
Dec 31, 2021	2.09B	92.47M	4.63%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error